"First-in-human" Study To Assess the Safety and Tolerability of PBF-677 in Healthy Volunteers
NCT02639975
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Glaucoma
Interventions
DRUG:
PBF-677
DRUG:
Placebo
Sponsor
Palobiofarma SL